Characterization/NN
of/IN
Chromatin/NN
Structure-associated/JJ
Histone/NN
Modifications/NNS
in/IN
Breast/NN
Cancer/NN
Cells/NNS
./.
====================
Chromatin/NN
structure/NN
and/CC
dynamics/NNS
that/DT
are/VBP
influenced/VBN
by/IN
epigenetic/JJ
marks/NNS
,/,
such/JJ
as/IN
histone/NN
modification/NN
and/CC
DNA/NN
methylation/NN
,/,
play/VBP
a/DT
crucial/JJ
role/NN
in/IN
modulating/VBG
gene/NN
transcription/NN
./.
====================
To/TO
understand/VB
the/DT
relationship/NN
between/IN
histone/NN
modifications/NNS
and/CC
regulatory/JJ
elements/NNS
in/IN
breast/NN
cancer/NN
cells/NNS
,/,
we/PRP
compared/VBD
our/PRP$
chromatin/NN
immunoprecipitation/NN
sequencing/NN
(/(
ChIP-Seq/NNP
)/)
histone/NN
modification/NN
patterns/NNS
for/IN
histone/NN
H3K4me1/NN
,/,
H3K4me3/NNP
,/,
H3K9/16ac/NNP
,/,
and/CC
H3K27me3/NN
in/IN
MCF-7/NN
cells/NNS
with/IN
publicly/RB
available/JJ
formaldehyde-assisted/VBN
isolation/NN
of/IN
regulatory/JJ
elements/NNS
(/(
FAIRE/NN
)/)
-chip/NN
signals/NNS
in/IN
human/JJ
chromosomes/NNS
8/CD
,/,
11/CD
,/,
and/CC
12/CD
,/,
identified/VBD
by/IN
a/DT
method/NN
called/VBN
FAIRE/NN
./.
====================
Active/JJ
regulatory/JJ
elements/NNS
defined/VBN
by/IN
FAIRE/NN
were/VBD
highly/RB
associated/VBN
with/IN
active/JJ
histone/NN
modifications/NNS
,/,
like/IN
H3K4me3/NN
and/CC
H3K9/16ac/NN
,/,
especially/RB
near/JJ
transcription/NN
start/NN
sites/NNS
./.
====================
The/DT
H3K9/16ac-enriched/JJ
genes/NNS
that/WDT
overlapped/VBD
with/IN
FAIRE/NN
signals/NNS
(/(
FAIRE-H3K9/14ac/NN
)/)
were/VBD
moderately/RB
correlated/VBD
with/IN
gene/NN
expression/NN
levels/NNS
./.
====================
We/PRP
also/RB
identified/VBD
functional/JJ
sequence/NN
motifs/NNS
at/IN
H3K4me1-enriched/JJ
FAIRE/NN
sites/NNS
upstream/RB
of/IN
putative/JJ
promoters/NNS
,/,
suggesting/VBG
that/IN
regulatory/JJ
elements/NNS
could/MD
be/VB
associated/VBN
with/IN
H3K4me1/NN
to/TO
be/VB
regarded/VBN
as/IN
distal/JJ
regulatory/JJ
elements/NNS
./.
====================
Our/PRP$
results/NNS
might/MD
provide/VB
an/DT
insight/NN
into/IN
epigenetic/JJ
regulatory/JJ
mechanisms/NNS
explaining/VBG
the/DT
association/NN
of/IN
histone/NN
modifications/NNS
with/IN
open/JJ
chromatin/NN
structure/NN
in/IN
breast/NN
cancer/NN
cells/NNS
./.
====================
The/DT
epigenetic/JJ
regulation/NN
by/IN
DNA/NN
methylation/NN
and/CC
post-translational/JJ
modifications/NNS
of/IN
histones/NNS
without/IN
altering/VBG
DNA/NN
sequences/NNS
is/VBZ
tightly/RB
linked/VBN
to/TO
the/DT
gene/NN
expression/NN
program/NN
in/IN
eukaryotic/JJ
genomes/NNS
./.
====================
The/DT
N-terminal/JJ
tails/NNS
of/IN
histones/NNS
are/VBP
subject/JJ
to/TO
various/JJ
types/NNS
of/IN
modifications/NNS
,/,
such/JJ
as/IN
acetylation/NN
,/,
methylation/NN
,/,
phosphorylation/NN
,/,
ubiquitination/NN
,/,
glycosylation/NN
,/,
and/CC
sumoylation/NN
[/(
1/CD
]/)
./.
====================
Dynamic/JJ
changes/NNS
by/IN
histone-modifying/VBG
enzymes/NNS
affect/VBP
the/DT
chromatin/NN
accessibility/NN
to/TO
transcriptional/JJ
machinery/NN
and/CC
thus/RB
modulate/VBP
gene/NN
activation/NN
or/CC
silencing/JJ
in/IN
diverse/JJ
biological/JJ
processes/NNS
,/,
such/JJ
as/IN
transcription/NN
,/,
DNA/NN
repair/NN
,/,
development/NN
and/CC
differentiation/NN
,/,
and/CC
genome/NN
stability/NN
[/(
2-4/CD
]/)
./.
====================
Moreover/RB
,/,
nucleosome/JJ
positioning/JJ
can/MD
also/RB
be/VB
controlled/VBN
by/IN
specific/JJ
histone/NN
modifications/NNS
,/,
leading/VBG
to/TO
alteration/NN
of/IN
cross-talk/NN
among/IN
chromatin/NN
structure/NN
,/,
exon-intron/NN
architecture/NN
,/,
and/CC
RNA/NN
polymerase/NN
II/CD
binding/NN
[/(
5/CD
,/,
6/CD
]/)
./.
====================
Genomewide/NN
profiles/NNS
of/IN
histone/NN
modifications/NNS
with/IN
chromatin/NN
immunoprecipitation/NN
sequencing/NN
(/(
ChIP-Seq/NN
)/)
have/VBP
revealed/VBN
the/DT
characteristic/JJ
genomic/JJ
distribution/NN
and/CC
the/DT
association/NN
of/IN
gene/NN
functions/NNS
and/CC
activities/NNS
in/IN
eukaryotic/JJ
genomes/NNS
[/(
7-12/CD
]/)
./.
====================
ChIP-Seq/NN
is/VBZ
a/DT
popularly/JJ
used/VBN
method/NN
to/TO
find/VB
genomewide/NN
protein/NN
binding/NN
sites/NNS
with/IN
a/DT
high/JJ
resolution/NN
by/IN
chromatin-immunoprecipitation/NN
by/IN
massive/JJ
DNA/NN
sequencing/NN
using/VBG
high-throughput/JJ
sequencing/NN
technology/NN
[/(
11/CD
]/)
./.
====================
For/IN
example/NN
,/,
trimethylated/VBD
histone/NN
H3/NN
lysine/NN
4/CD
(/(
H3K4me3/NN
)/)
,/,
which/WDT
is/VBZ
catalyzed/VBN
by/IN
trithorax/NN
complex/NN
,/,
as/IN
well/RB
as/IN
histone/NN
acetylation/NN
(/(
e.g./FW
,/,
H3K9/16ac/NNP
)/)
are/VBP
usually/RB
enriched/JJ
at/IN
promoter/NN
regions/NNS
or/CC
transcription/NN
start/NN
sites/NNS
(/(
TSSs/NNS
)/)
with/IN
open/JJ
chromatin/NN
structure/NN
and/CC
positively/RB
correlated/VBD
with/IN
gene/NN
transcriptional/JJ
activation/NN
level/NN
./.
====================
H3K4me1/NN
is/VBZ
also/RB
found/VBD
to/TO
be/VB
enriched/VBN
at/IN
enhancer-associated/JJ
regions/NNS
./.
====================
These/DT
modifications/NNS
recruit/VBP
the/DT
transcriptional/JJ
machinery/NN
at/IN
target/NN
sites/NNS
./.
====================
Trimethylation/NN
of/IN
H3K27/NN
,/,
catalyzed/VBD
by/IN
polycomb/NN
group/NN
protein/NN
complex/NN
2/CD
(/(
PRC2/NN
)/)
,/,
contributes/VBZ
to/TO
gene/NN
silencing/NN
by/IN
promoting/VBG
chromatin/NN
condensation/NN
and/CC
chromatin/NN
stabilization/NN
and/CC
is/VBZ
likely/JJ
to/TO
spread/VBN
over/IN
larger/RBR
regions/NNS
around/IN
TSSs/NNS
of/IN
silent/JJ
genes/NNS
./.
====================
The/DT
signals/NNS
of/IN
H3K9me3/NN
are/VBP
high/JJ
in/IN
silent/JJ
genes/NNS
or/CC
repressed/VBN
chromatin/NN
domains/NNS
,/,
such/JJ
as/IN
heterochromatin/NN
./.
====================
The/DT
comprehensive/JJ
and/CC
comparative/JJ
analysis/NN
of/IN
many/JJ
histone/NN
modifications/NNS
in/IN
the/DT
human/JJ
genome/NN
demonstrates/VBZ
that/IN
the/DT
combination/NN
of/IN
several/JJ
histone/NN
modifications/NNS
shows/VBZ
a/DT
modular/JJ
pattern/NN
and/CC
regulates/VBZ
transcriptional/JJ
activation/NN
in/IN
a/DT
cooperative/JJ
manner/NN
[/(
13/CD
]/)
./.
====================
Interestingly/RB
,/,
many/JJ
loci/NNS
of/IN
H3K27me3/NN
are/VBP
often/RB
colocalized/VBD
with/IN
those/DT
of/IN
H3K4me3/NN
around/IN
TSSs/NNS
of/IN
lowly/RB
expressed/VBN
genes/NNS
in/IN
stem-like/JJ
cells/NNS
,/,
many/JJ
of/IN
which/WDT
are/VBP
positioned/VBN
at/IN
developmental/JJ
regulators/NNS
,/,
including/VBG
transcription/NN
factors/NNS
and/CC
signaling/NN
proteins/NNS
[/(
14/CD
]/)
./.
====================
This/DT
suggests/VBZ
that/IN
the/DT
formation/NN
of/IN
a/DT
bivalent/JJ
chromatin/NN
domain/NN
can/MD
be/VB
a/DT
signature/JJ
of/IN
epigenetic/JJ
memory/NN
and/CC
that/IN
programmed/VBN
gene/NN
expression/NN
during/IN
differentiation/NN
is/VBZ
dependent/JJ
on/IN
chromatin/NN
modifications/NNS
[/(
14/CD
]/)
./.
====================
The/DT
interactions/NNS
of/IN
variations/NNS
in/IN
the/DT
genome/NN
,/,
epigenome/JJ
,/,
and/CC
transcriptome/VBP
with/IN
sensing/VBG
of/IN
environmental/JJ
stimuli/NNS
can/MD
determine/VB
phenotypic/JJ
plasticity/NN
./.
====================
Traditionally/RB
,/,
phenotypic/JJ
variation/NN
has/VBZ
been/VBN
explained/VBN
primarily/RB
through/IN
genetic/JJ
variation/NN
with/IN
sequence/NN
changes/NNS
during/IN
evolution/NN
./.
====================
However/RB
,/,
epigenetic/JJ
variations/NNS
that/IN
are/VBP
potentially/RB
sensitive/JJ
to/TO
environmental/JJ
inputs/NNS
can/MD
alter/VB
transcriptional/JJ
activity/NN
,/,
which/WDT
in/IN
turn/NN
contributes/VBZ
to/TO
diversity/NN
of/IN
complex/NN
traits/VBZ
[/(
15/CD
]/)
./.
====================
Such/JJ
observations/NNS
have/VBP
been/VBN
demonstrated/VBN
in/IN
human/JJ
cancers/NNS
and/CC
plant/JJ
development/NN
,/,
such/JJ
as/IN
floral/JJ
symmetry/NN
and/CC
vernalization/NN
response/NN
(/(
reviewed/VBD
in/IN
[/(
15/CD
,/,
16/CD
]/)
)/)
./.
====================
For/IN
example/NN
,/,
silencing/VBG
of/IN
tumor/NN
suppressor/NN
genes/NNS
,/,
including/VBG
p16/NN
,/,
VHL/NN
,/,
MLH1/NN
,/,
APC/NN
,/,
and/CC
E-cadherin/NN
,/,
is/VBZ
associated/VBN
with/IN
DNA/NN
hypermethylation/NN
in/IN
the/DT
gene/NN
promoters/NNS
[/(
17/CD
]/)
./.
====================
In/IN
relation/NN
to/TO
histone/NN
modifications/NNS
,/,
overexpression/NN
of/IN
EZH2/NN
,/,
a/DT
histone/NN
H3K27/NN
methyltransferase/NN
,/,
has/VBZ
been/VBN
observed/VBN
and/CC
positively/RB
correlated/VBD
with/IN
the/DT
progression/NN
of/IN
multiple/JJ
malignancies/NNS
,/,
including/VBG
prostate/NN
cancer/NN
,/,
breast/NN
cancer/NN
,/,
lymphoma/NN
,/,
myeloma/NN
,/,
colorectal/JJ
cancer/NN
,/,
endometrial/JJ
cancer/NN
,/,
bladder/RB
cancer/NN
,/,
and/CC
melanoma/NN
[/(
18/CD
]/)
./.
====================
In/IN
addition/NN
,/,
generalized/VBN
loss/NN
of/IN
H4K16ac/JJ
and/CC
H4K20me3/NN
is/VBZ
found/VBN
in/IN
lymphoma/NN
and/CC
colorectal/JJ
cancer/NN
,/,
leading/VBG
to/TO
transcriptional/JJ
silencing/NN
[/(
16/CD
]/)
./.
====================
Organization/NN
of/IN
genomic/JJ
DNA/NN
into/IN
higher-order/JJ
chromatin/NN
structures/NNS
is/VBZ
involved/VBN
in/IN
transcriptional/JJ
regulation/NN
in/IN
eukaryotes/NNS
[/(
19/CD
,/,
20/CD
]/)
./.
====================
In/IN
particular/JJ
,/,
cis-regulatory/JJ
elements/NNS
complexes/NNS
located/JJ
in/IN
open/JJ
chromatin/NN
regions/NNS
,/,
depleted/VBN
of/IN
nucleosomes/NNS
,/,
are/VBP
activated/VBN
by/IN
the/DT
recruitment/NN
of/IN
transcriptional/JJ
machinery/NN
[/(
19/CD
,/,
20/CD
]/)
./.
====================
Such/JJ
active/JJ
regulatory/JJ
elements/NNS
have/VBP
been/VBN
identified/VBN
by/IN
formaldehyde-assisted/VBN
isolation/NN
of/IN
regulatory/JJ
elements/NNS
(/(
FAIRE/NN
)/)
technique/NN
,/,
a/DT
simple/JJ
high-throughput/RB
screening/VBG
method/NN
to/TO
isolate/VB
and/CC
map/VBP
active/JJ
regulatory/JJ
elements/NNS
depleted/VBD
of/IN
nucleosomes/NNS
in/IN
eukaryotes/NNS
,/,
especially/RB
in/IN
clinical/JJ
samples/NNS
,/,
by/IN
forming/VBG
crosslinks/NNS
between/IN
histones/NNS
and/CC
DNA/NN
and/CC
subsequent/JJ
utilization/NN
of/IN
hybridization/NN
of/IN
tiling/JJ
microarrays/NNS
or/CC
next-generation/JJ
sequencing/NN
[/(
21-23/CD
]/)
./.
====================
FAIRE/NN
was/VBD
first/JJ
demonstrated/VBD
in/IN
Saccharomyces/NN
cerevisiae/NN
,/,
where/WRB
formaldehyde-crosslinked/VBD
chromatin/NN
immediately/RB
upstream/RB
of/IN
genes/NNS
was/VBD
preferentially/RB
segregated/VBD
into/IN
the/DT
aqueous/JJ
phase/NN
in/IN
a/DT
manner/NN
that/IN
was/VBD
strongly/RB
negatively/RB
correlated/VBD
with/IN
nucleosome/JJ
occupancy/NN
[/(
21/CD
]/)
./.
====================
Results/NNS
from/IN
both/DT
yeast/NN
and/CC
human/JJ
samples/NNS
showed/VBD
that/IN
enrichment/JJ
of/IN
regions/NNS
upstream/RB
of/IN
genes/NNS
was/VBD
positively/RB
correlated/VBD
with/IN
transcription/NN
of/IN
downstream/JJ
genes/NNS
[/(
21-23/CD
]/)
./.
====================
Breast/NN
cancer/NN
is/VBZ
a/DT
heterogeneous/JJ
and/CC
progressive/JJ
disease/NN
,/,
known/VBN
as/IN
the/DT
most/JJS
common/JJ
cancer/NN
among/IN
women/NNS
./.
====================
For/IN
early/JJ
diagnosis/NN
and/CC
prognosis/NN
,/,
the/DT
development/NN
of/IN
tumor/NN
makers/NNS
in/IN
breast/NN
cancer/NN
is/VBZ
important/JJ
,/,
but/CC
the/DT
markers/NNS
for/IN
its/PRP$
early/JJ
detection/NN
are/VBP
rare/JJ
[/(
24/CD
,/,
25/CD
]/)
./.
====================
The/DT
most/JJS
clinically/RB
useful/JJ
tissue-based/JJ
marker/NN
genes/NNS
in/IN
breast/NN
cancer/NN
are/VBP
steroid/NN
receptors/NNS
,/,
estrogen/NN
receptors/NNS
,/,
progesterone/NN
receptors/NNS
,/,
and/CC
HER-2/NN
[/(
24/CD
,/,
25/CD
]/)
./.
====================
The/DT
mutations/NNS
of/IN
BRCA1/NN
and/CC
BRCA2/NN
are/VBP
strong/JJ
indicators/NNS
of/IN
breast/NN
cancer/NN
development/NN
,/,
but/CC
their/PRP$
mutation/NN
is/VBZ
not/RB
common/JJ
[/(
25/CD
]/)
./.
====================
Except/IN
for/IN
genetic/JJ
variation-based/VBD
diagnosis/NN
,/,
a/DT
comprehensive/JJ
understanding/NN
of/IN
the/DT
gene/NN
expression/NN
program/NN
as/IN
well/RB
as/IN
epigenetic/JJ
mechanisms/NNS
is/VBZ
definitely/RB
required/VBN
for/IN
the/DT
development/NN
of/IN
diagnosis/NN
markers/NNS
and/CC
epigenetic/JJ
therapies/NNS
./.
====================
We/PRP
recently/RB
reported/VBN
epigenetic/JJ
regulatory/JJ
mechanisms/NNS
of/IN
gene/NN
expression/NN
with/IN
3/CD
different/JJ
histone/NN
modifications/NNS
(/(
H3K4me1/NN
,/,
H3K4me3/NN
,/,
and/CC
H3K9/14ac/NN
)/)
in/IN
normal/JJ
(/(
MCF-10A/NN
)/)
and/CC
breast/NN
cancer/NN
(/(
MCF-7/NN
)/)
cells/NNS
[/(
26/CD
]/)
./.
====================
In/IN
particular/JJ
,/,
we/PRP
demonstrated/VBD
the/DT
change/NN
of/IN
transcriptional/JJ
activity/NN
,/,
delineating/VBG
differential/JJ
enrichment/JJ
of/IN
histone/NN
modifications/NNS
in/IN
both/DT
MCF-10A/NN
and/CC
MCF-7/NN
,/,
which/WDT
defines/VBZ
the/DT
functional/JJ
regulatory/JJ
elements/NNS
in/IN
the/DT
genome/NN
with/IN
a/DT
cell/NN
type-specific/JJ
chromatin/NN
environment/NN
[/(
26/CD
]/)
./.
====================
To/TO
address/VB
the/DT
relationships/NNS
between/IN
histone/NN
modifications/NNS
and/CC
FAIRE/NN
and/CC
between/IN
FAIRE-related/JJ
chromatin/NN
structure/NN
and/CC
transcriptional/JJ
activity/NN
,/,
we/PRP
analyzed/VBD
FAIRE-chip/NN
[/(
23/CD
]/)
,/,
histone/NN
modification-ChIP-Seq/NN
[/(
26/CD
]/)
,/,
and/CC
gene/NN
expression/NN
microarrays/NNS
derived/VBN
from/IN
MCF-7/NN
./.
====================
Our/PRP$
result/NN
provides/VBZ
an/DT
understanding/NN
of/IN
epigenetic/JJ
regulatory/JJ
mechanisms/NNS
with/IN
open/JJ
chromatin/NN
in/IN
breast/NN
cancer/NN
cells/NNS
./.
====================
Subjects/NNS
====================
The/DT
FAIRE-chip/NN
data/NNS
,/,
covering/VBG
human/JJ
chromosomes/NNS
8/CD
,/,
11/CD
,/,
and/CC
12/CD
,/,
derived/VBN
from/IN
MCF-7/NN
cell/NN
lines/NNS
,/,
were/VBD
downloaded/VBN
from/IN
the/DT
NCBI/NN
Gene/NN
Expression/NN
Omnibus/FW
(/(
GEO/NN
)/)
database/NN
(/(
GSE11579/NN
)/)
[/(
23/CD
]/)
./.
====================
The/DT
ChIP-Seq/NN
data/NNS
(/(
SRA045635/NN
)/)
of/IN
H3K4me1/NN
,/,
H3K4me3/NN
,/,
H3K9/14ac/NN
,/,
and/CC
input/NN
DNA/NN
(/(
mononucleosome/JJ
digested/JJ
with/IN
micrococcal/JJ
nuclease/NN
)/)
in/IN
MCF-7/NN
were/VBD
obtained/VBN
from/IN
the/DT
Sequence/NN
Read/NN
Archive/JJ
(/(
SRA/NN
)/)
at/IN
the/DT
National/JJ
Center/JJ
for/IN
Biotechnical/JJ
Information/NN
(/(
NCBI/LS
)/)
[/(
26/CD
]/)
./.
====================
The/DT
H3K27me3/NN
ChIP-Seq/NN
data/NNS
were/VBD
generated/VBN
with/IN
Genome/NN
Analyzer/NN
IIx/NN
(/(
Illumina/NN
Inc./NNP
,/,
San/NNP
Diego/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
according/VBG
to/TO
the/DT
method/NN
described/VBN
by/IN
Choe/NN
et/FW
al/JJ
./.
====================
[/(
26/CD
]/)
./.
====================
The/DT
gene/NN
expression/NN
data/NNS
using/VBG
the/DT
Human/JJ
Genome/NN
U133Plus/NN
2.0/CD
array/NN
platform/NN
(/(
Affymetrix/JJ
Inc./NNP
,/,
Santa/NN
Clara/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
were/VBD
collected/VBN
from/IN
the/DT
GEO/NN
database/NN
(/(
GSM276046-GSM276048/NN
for/IN
MCF-7/NN
)/)
[/(
27/CD
]/)
./.
====================
Peak/JJ
identification/NN
and/CC
statistical/JJ
analysis/NN
====================
The/DT
FAIRE-chip/NN
data/NNS
were/VBD
processed/VBN
by/IN
using/VBG
CisGenome/JJ
[/(
28/CD
]/)
for/IN
normalization/NN
,/,
signal/NN
detection/NN
,/,
and/CC
identification/NN
of/IN
significant/JJ
FAIRE/NN
regions/NNS
./.
====================
The/DT
26-bp/JJ
ChIP-Seq/NN
reads/VBZ
for/IN
H3K4me1/NN
,/,
H3K4me3/NN
,/,
H3K9/14ac/NN
,/,
H3K27me3/NN
,/,
and/CC
input/NN
DNA/NN
were/VBD
aligned/VBN
to/TO
a/DT
human/JJ
reference/NN
sequence/NN
(/(
hg18/CD
)/)
using/VBG
the/DT
CASABA/NN
1.6/CD
program/NN
(/(
Illumina/NN
Inc./NNP
)/)
,/,
and/CC
the/DT
resulting/VBG
mapped/VBD
tag/NN
counts/NNS
were/VBD
normalized/VBN
for/IN
the/DT
comparative/JJ
analysis/NN
./.
====================
To/TO
identify/VB
peaks/VBZ
enriched/JJ
with/IN
a/DT
specific/JJ
histone/NN
modification/NN
,/,
the/DT
Hypergeometric/JJ
Optimization/JJ
of/IN
Motif/JJ
EnRichment/JJ
(/(
HOMER/NN
)/)
package/NN
version/RB
3.2/CD
[/(
29/CD
]/)
was/VBD
used/VBN
with/IN
the/DT
following/VBG
options/NNS
:/:
approximate/JJ
fragment/NN
length/NN
,/,
150/CD
bp/NN
;/:
peak/RB
size/NN
,/,
150/CD
bp/NN
;/:
minimum/JJ
distance/RB
between/IN
peaks/VBZ
,/,
370/CD
bp/NN
(/(
equivalent/JJ
to/TO
peak/JJ
size/NN
×/NNP
2.5/CD
)/)
;/:
Poisson/NNP
p-value/JJ
threshold/RB
relative/JJ
to/TO
local/JJ
tag/NN
count/RB
,/,
0.0001/CD
;/:
default/RB
false/RB
discovery/RB
rate/RB
threshold/RB
,/,
0.001/CD
;/:
and/CC
center/JJ
switch/NN
for/IN
centering/JJ
peaks/VBZ
on/IN
maximum/JJ
ChIP/NN
fragment/NN
overlap/IN
and/CC
calculating/JJ
focus/IN
ratios/NNS
./.
====================
The/DT
FAIRE/NN
sites/NNS
coinciding/VBG
with/IN
histone-modified/JJ
peaks/VBZ
were/VBD
defined/VBN
when/WRB
the/DT
distance/NN
between/IN
the/DT
center/NN
positions/NNS
of/IN
FAIRE/NN
sites/NNS
and/CC
histone-modified/VBD
peaks/VBZ
was/VBD
shorter/JJR
than/IN
100/CD
base/NN
pairs/NNS
./.
====================
The/DT
co-existing/VBG
sites/NNS
of/IN
FAIRE/NN
and/CC
histone/NN
modifications/NNS
were/VBD
plotted/VBN
,/,
centered/JJ
at/IN
the/DT
genes/NNS
'/``
TSSs/NNS
using/VBG
seqMINER/NN
with/IN
k-mean/JJ
clustering/NN
method/NN
[/(
30/CD
]/)
./.
====================
Expression/NN
levels/NNS
of/IN
genes/NNS
associated/VBN
with/IN
the/DT
FAIRE-histone-modified/JJ
regions/NNS
were/VBD
examined/VBN
,/,
and/CC
gene/NN
ontology/NN
(/(
GO/NN
)/)
enrichment/JJ
and/CC
Kyoto/NN
Encyclopedia/NN
of/IN
Genes/NNS
and/CC
Genomes/NNS
(/(
KEGG/NN
)/)
pathway/NN
analysis/NN
were/VBD
performed/VBN
by/IN
using/VBG
the/DT
DAVID/NN
Functional/JJ
Annotation/NN
Tool/NN
[/(
31/CD
]/)
./.
====================
In/IN
addition/NN
,/,
functional/JJ
,/,
enriched/JJ
motifs/NNS
in/IN
FAIRE-histone-modified/JJ
regions/NNS
were/VBD
also/RB
found/VBD
by/IN
using/VBG
MEME/NN
suite/JJ
[/(
32/CD
]/)
and/CC
the/DT
TOMTOM/NN
motif/NN
database/NN
[/(
33/CD
]/)
./.
====================
Chromatin/NN
structure/NN
defined/VBN
by/IN
FAIRE/NN
and/CC
histone/NN
modifications/NNS
====================
The/DT
chromatin/NN
structure/NN
was/VBD
analyzed/VBN
by/IN
comparing/VBG
genomic/JJ
regions/NNS
defined/VBN
by/IN
FAIRE/NN
with/IN
histone/NN
modification/NN
sites/NNS
detected/VBN
by/IN
ChIP-Seq/NN
in/IN
a/DT
breast/NN
cancer/NN
cell/NN
line/NN
,/,
MCF-7/NN
./.
====================
Due/IN
to/TO
the/DT
limited/JJ
information/NN
of/IN
FAIRE-chip/NN
data/NNS
,/,
we/PRP
analyzed/VBD
regions/NNS
enriched/JJ
in/IN
human/JJ
chromosomes/NNS
8/CD
,/,
11/CD
,/,
and/CC
12/CD
./.
====================
The/DT
overall/JJ
positions/NNS
of/IN
regulatory/JJ
elements/NNS
and/CC
histone/NN
modifications/NNS
relative/JJ
to/TO
TSS/NN
are/VBP
depicted/VBN
in/IN
Fig/NN
./.
====================
1A/NN
./.
====================
The/DT
k-clustered/JJ
pattern/NN
,/,
depending/VBG
on/IN
their/PRP$
enrichment/JJ
level/NN
,/,
showed/VBD
that/IN
most/JJS
H3K4me3/NN
and/CC
H3K9/14ac/NN
modifications/NNS
,/,
known/VBN
as/IN
active/JJ
chromatin/NN
marks/NNS
,/,
were/VBD
enriched/VBN
near/JJ
TSS/NN
,/,
whereas/IN
H3K27me3/NN
,/,
a/DT
repressive/JJ
mark/VBP
,/,
was/VBD
not/RB
./.
====================
Many/JJ
regulatory/JJ
elements/NNS
detected/VBN
by/IN
FAIRE-chip/NN
were/VBD
also/RB
located/JJ
near/JJ
TSS/NN
,/,
reflecting/VBG
that/DT
promoters/NNS
are/VBP
one/CD
of/IN
the/DT
major/JJ
nucleosome-free/JJ
sites/NNS
./.
====================
The/DT
relative/JJ
positions/NNS
of/IN
3/CD
histone/NN
modification/NN
enrichments/NNS
(/(
H3K4me1/NN
,/,
H3K4me3/NN
,/,
and/CC
H3K9/14ac/NN
)/)
were/VBD
aligned/VBN
to/TO
the/DT
center/NN
of/IN
FAIRE/NN
signals/NNS
and/CC
overlapped/VBD
within/IN
±/CD
1-kb/JJ
regions/NNS
from/IN
TSSs/NN
(/(
Fig/NN
./.
====================
1B/NN
)/)
./.
====================
The/DT
H3K4me1/NN
had/VBD
a/DT
broader/JJR
spectrum/NN
than/IN
the/DT
other/JJ
2/CD
modifications/NNS
in/IN
±/NN
0.5-1.5-kb/JJ
regions/NNS
./.
====================
These/DT
results/NNS
implied/VBD
that/DT
regulatory/JJ
elements/NNS
were/VBD
highly/RB
correlated/VBD
with/IN
active/JJ
histone/NN
modifications/NNS
and/CC
associated/VBN
with/IN
open/JJ
chromatin/NN
structure/NN
./.
====================
A/DT
total/JJ
of/IN
2,804/CD
regulatory/JJ
elements/NNS
from/IN
FAIRE-chip/NN
data/NNS
were/VBD
identified/VBN
by/IN
CisGenome/NN
analysis/NN
,/,
and/CC
the/DT
number/NN
of/IN
ChIP-Seq/NN
peaks/VBZ
was/VBD
calculated/VBN
using/VBG
HOMER/NN
program/NN
:/:
18,938/CD
for/IN
HK4me1/NN
,/,
4,516/CD
for/IN
H3K4me3/NN
,/,
5,763/CD
for/IN
H3K9/14ac/JJ
,/,
and/CC
3,324/CD
for/IN
H3K27me3/NN
(/(
Table/JJ
1/CD
)/)
./.
====================
The/DT
FAIRE/NN
sites/NNS
were/VBD
located/JJ
in/IN
especially/RB
functional/JJ
element-related/JJ
regions/NNS
:/:
promoters/NNS
(/(
32.2/CD
%/NN
of/IN
FAIRE/NN
sites/NNS
analyzed/VBD
)/)
,/,
4/CD
kb/NN
upstream/RB
of/IN
promoters/NNS
(/(
3.2/CD
%/NN
)/)
,/,
gene/NN
bodies/NNS
(/(
39.1/CD
%/NN
)/)
,/,
and/CC
intergenic/JJ
regions/NNS
(/(
25.4/CD
%/NN
)/)
./.
====================
In/IN
particular/JJ
,/,
the/DT
highest/JJS
enrichment/JJ
of/IN
FAIREs/NNS
in/IN
promoters/NNS
could/MD
be/VB
identified/VBN
by/IN
the/DT
normalization/NN
in/IN
quantitative/JJ
comparison/NN
of/IN
FAIRE/NN
profiles/NNS
(/(
i.e./FW
,/,
the/DT
total/JJ
number/NN
of/IN
peaks/total/JJ
length/NN
of/IN
each/DT
of/IN
genomic/JJ
feature/NN
)/)
./.
====================
We/PRP
selected/VBD
the/DT
overlapping/VBG
regulatory/JJ
elements/NNS
of/IN
FAIRE/NN
signals/NNS
with/IN
ChIP-Seq/NN
peaks/VBZ
and/CC
looked/VBD
at/IN
their/PRP$
co-occurrence/NN
;/:
the/DT
regulatory/JJ
elements/NNS
with/IN
H3K4me1/NN
(/(
FAIRE-H3K4me1/NN
)/)
were/VBD
1,006/CD
;/:
FAIRE-H3K4me3/NN
,/,
1,000/CD
;/:
and/CC
FAIRE-H3K9/14ac/NN
,/,
1,264/NN
./.
====================
Among/IN
them/PRP
,/,
334/CD
elements/NNS
showed/VBD
enrichment/JJ
of/IN
both/DT
H3K4me3/NN
and/CC
H3K9/14ac/NN
(/(
Fig/NN
./.
====================
1C/NN
)/)
./.
====================
This/DT
relationship/NN
was/VBD
further/RBR
confirmed/VBD
by/IN
the/DT
distribution/NN
of/IN
FAIRE-histone/NN
modifications/NNS
,/,
shown/VBN
in/IN
Fig/NN
./.
====================
1D/CD
./.
====================
The/DT
highest/JJS
population/NN
of/IN
FAIRE-H3K4me3/NN
and/CC
FAIRE-H3K9/14ac/NN
was/VBD
observed/VBN
immediately/RB
downstream/JJ
of/IN
TSS/NN
(/(
Fig/NN
./.
====================
1D/CD
)/)
./.
====================
A/DT
weak/JJ
enrichment/JJ
of/IN
FAIRE-H3K4me1/NN
elements/NNS
was/VBD
detected/VBN
upstream/RB
of/IN
TSS/NN
,/,
where/WRB
a/DT
shoulder/JJ
peak/NN
of/IN
FAIRE-H3K4me1/NN
and/CC
H3K4me3/NN
was/VBD
positioned/VBN
./.
====================
For/IN
example/NN
,/,
4/CD
FAIRE/NN
regulatory/JJ
elements/NNS
of/IN
cyclin/NN
D1/NN
(/(
CCND1/NN
)/)
,/,
involved/VBN
in/IN
tumorigenesis/NN
as/IN
a/DT
cell/NN
cycle/NN
regulator/NN
,/,
were/VBD
located/JJ
at/IN
the/DT
promoter/NN
and/CC
overlapped/VBD
with/IN
peaks/NNS
of/IN
H3K4me3/NN
and/CC
H3K9/14ac/NN
but/CC
not/RB
with/IN
H3K4me1/NN
or/CC
H3K27me3/NN
(/(
Fig/NN
./.
====================
1E/NN
)/)
./.
====================
Instead/RB
,/,
the/DT
H3K4me1/NN
peaks/VBZ
in/IN
the/DT
CCND1/NN
gene/NN
locus/NN
were/VBD
expanded/VBN
along/IN
the/DT
gene/NN
body/NN
and/CC
far/RB
upstream/RB
of/IN
TSS/NN
./.
====================
Gene/NN
expression/NN
and/CC
FAIRE-histone/NN
modifications/NNS
====================
The/DT
gene/NN
expression/NN
program/NN
is/VBZ
tightly/RB
controlled/VBN
by/IN
a/DT
dynamic/JJ
chromatin/NN
environment/NN
,/,
which/WDT
epigenetic/JJ
factors/NNS
,/,
like/IN
histone/NN
modifications/NNS
and/CC
DNA/NN
methylation/NN
,/,
play/VBP
a/DT
crucial/JJ
role/NN
in/IN
determining/VBG
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
1/CD
,/,
we/PRP
found/VBD
the/DT
linkage/NN
of/IN
FAIRE/NN
regulatory/JJ
elements/NNS
with/IN
histone/NN
modification/NN
profiles/NNS
./.
====================
To/TO
further/RBR
assess/VB
the/DT
FAIRE-histone/NN
modifications/NNS
,/,
the/DT
gene/NN
expression/NN
profiles/NNS
for/IN
MCF-7/NN
cells/NNS
were/VBD
integrated/VBN
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
From/IN
the/DT
overlapped/VBN
regulatory/JJ
elements/NNS
determined/VBN
by/IN
comparison/NN
of/IN
FARE-H3K4me1/NN
(/(
1,006/CD
)/)
,/,
FAIRE-H3K4me3/NN
(/(
1,000/CD
)/)
,/,
and/CC
FAIRE-H3K9/14ac/NN
(/(
1,264/CD
)/)
,/,
we/PRP
selected/VBD
229/CD
genes/NNS
associated/VBN
with/IN
at/IN
least/JJS
2/CD
of/IN
3/CD
FAIRE-histone/NN
modification/NN
combinations/NNS
./.
====================
Scatter/NN
plots/NNS
were/VBD
produced/VBN
to/TO
see/VB
how/WRB
the/DT
expression/NN
level/NN
agreed/RB
with/IN
degree/NN
of/IN
histone/NN
modification/NN
(/(
Fig/NN
./.
====================
2A-2C/NN
)/)
./.
====================
The/DT
Pearson/NN
correlation/NN
coefficients/NNS
between/IN
histone/NN
modifications/NNS
and/CC
the/DT
expression/NN
level/NN
of/IN
genes/NNS
with/IN
FAIRE/NN
elements/NNS
were/VBD
generally/RB
low/JJ
./.
====================
The/DT
highest/JJS
coefficient/JJ
was/VBD
r/NN
=/JJ
0.50/CD
for/IN
the/DT
pair/NN
of/IN
gene/NN
expression/NN
and/CC
FAIRE-H3K9/14ac/NN
(/(
Fig/NN
./.
====================
2C/NN
)/)
,/,
and/CC
the/DT
next/JJ
was/VBD
r/NN
=/JJ
0.4/CD
for/IN
gene/NN
expression/NN
and/CC
FAIRE-H3K4me3/NN
(/(
Fig/NN
./.
====================
2B/NN
)/)
./.
====================
However/RB
,/,
FAIRE-H3K4me1/NN
showed/VBD
almost/RB
no/DT
correlation/NN
with/IN
gene/NN
expression/NN
level/NN
(/(
r/NN
=/JJ
-0.03/CD
)/)
(/(
Fig/NN
./.
====================
2A/NN
)/)
./.
====================
To/TO
examine/VB
whether/IN
breast/NN
cancer-related/JJ
genes/NNS
were/VBD
up-regulated/VBN
in/IN
MCF-7/NN
and/CC
appeared/VBD
to/TO
have/VB
a/DT
high/JJ
level/NN
of/IN
H3K9/14ac/JJ
,/,
as/IN
found/VBN
in/IN
our/PRP$
previous/JJ
study/NN
[/(
26/CD
]/)
,/,
we/PRP
selected/VBD
68/CD
genes/NNS
,/,
the/DT
expression/NN
levels/NNS
of/IN
which/WDT
ranked/VBD
in/IN
the/DT
top/NN
30/CD
%/NN
among/IN
FAIRE-H3K9/14ac-associated/JJ
genes/NNS
,/,
and/CC
performed/VBN
DAVID/NN
Functional/JJ
Annotation/NN
analysis/NN
./.
====================
We/PRP
could/MD
isolate/VB
29/CD
functionally/RB
significant/JJ
genes/NNS
with/IN
p/NN
</JJR
0.05/CD
:/:
ATM/NN
,/,
BTG1/NN
,/,
CCND1/NN
,/,
CDK4/NN
,/,
CDKN1B/NN
,/,
CRADD/NN
,/,
CSDA/NN
,/,
CTR9/NN
,/,
DDB2/NN
,/,
DUSP6/NN
,/,
ERBB3/NN
,/,
ESPL1/NN
,/,
FADD/NN
,/,
H2AFX/NN
,/,
KRT18/NNP
,/,
KRT8/NNP
,/,
MADD/NN
,/,
MDM2/NN
,/,
MYC/NN
,/,
NR4A1/NN
,/,
POLA2/NN
,/,
RIPK2/NN
,/,
RRM2B/NN
,/,
SART3/NN
,/,
SMARCC2/NN
,/,
TSG101/NN
,/,
UBE2N/NNP
,/,
XPOT/NN
,/,
and/CC
YWHAZ/NN
./.
====================
These/DT
genes/NNS
were/VBD
associated/VBN
with/IN
the/DT
following/VBG
GO/NN
categories/NNS
:/:
regulation/NN
of/IN
apoptosis/NN
,/,
programmed/VBN
cell/NN
death/NN
,/,
nuclear/JJ
lumen/NNS
,/,
protein/NN
ubiquitination/NN
,/,
DNA/NN
damage/NN
checkpoint/NN
,/,
mitotic/JJ
cell/NN
cycle/NN
,/,
and/CC
small/JJ
conjugating/VBG
protein/NN
ligase/NN
activity/NN
(/(
Fig/NN
./.
====================
2D/CD
)/)
./.
====================
Moreover/RB
,/,
the/DT
KEGG/NN
pathway/NN
analysis/NN
displayed/VBD
their/PRP$
involvement/NN
in/IN
the/DT
cell/NN
cycle/NN
,/,
p53/NN
signaling/NN
pathway/NN
,/,
mitogen-activated/JJ
protein/NN
kinase/NN
signaling/NN
pathway/NN
,/,
and/CC
pathways/NNS
in/IN
cancer/NN
(/(
Fig/NN
./.
====================
2E/NN
)/)
./.
====================
Sequence/NN
motif/NN
analysis/NN
for/IN
FAIREs/NNS
marked/JJ
by/IN
active/JJ
histone/NN
modifications/NNS
====================
As/IN
many/JJ
FAIRE/NN
regulatory/JJ
elements/NNS
were/VBD
linked/VBN
with/IN
active/JJ
histone/NN
modifications/NNS
,/,
we/PRP
explored/VBD
the/DT
possible/JJ
existence/NN
of/IN
functional/JJ
sequence/NN
motifs/NNS
for/IN
known/VBN
transcription/NN
factors/NNS
in/IN
FAIRE-H3K4me3/NN
and/CC
FAIRE-H3K9/14ac/NN
sites/NNS
./.
====================
The/DT
binding/NN
motifs/NNS
,/,
such/JJ
as/IN
CTCF/NN
,/,
MYB/NN
,/,
GFY-staf/NN
,/,
ETS/NN
,/,
and/CC
NRF1/NN
,/,
were/VBD
common/JJ
in/IN
both/DT
FAIRE-H3K4me3/NN
and/CC
FAIRE-H3K9/14ac/NN
sites/NNS
(/(
Fig/NN
./.
====================
3A/NN
)/)
./.
====================
However/RB
,/,
NFY/NN
and/CC
RUNX/NN
motifs/NNS
existed/VBD
only/RB
in/IN
FAIRE-H3K4me3/NN
sites/NNS
,/,
and/CC
the/DT
GATA3/NN
motif/NN
was/VBD
specifically/RB
detected/VBN
in/IN
FAIRE-H3K9/14ac/NN
sites/NNS
./.
====================
For/IN
FAIRE-H3K4me1/NN
sites/NNS
,/,
AP-1/2/NN
,/,
NF1/NN
,/,
CTCF/NN
,/,
AP-2/NN
,/,
FOXA1/NN
,/,
USF1/NN
,/,
and/CC
MAFA/NN
motifs/NNS
were/VBD
identified/VBN
(/(
Fig/NN
./.
====================
3B/NN
)/)
./.
====================
Interestingly/RB
,/,
the/DT
CTCF/NN
motif/NN
was/VBD
commonly/RB
found/VBN
in/IN
FAIRE-H3K4me1/NN
,/,
FAIRE-H3K4me3/NN
,/,
and/CC
FAIRE-H3K9/14ac/NN
./.
====================
The/DT
genomewide/NN
positioning/JJ
of/IN
regulatory/JJ
elements/NNS
marked/JJ
by/IN
histone/NN
modifications/NNS
is/VBZ
illustrated/VBN
in/IN
a/DT
Venn/JJ
diagram/NN
(/(
Fig/NN
./.
====================
3C-3E/NN
)/)
./.
====================
More/RBR
than/IN
60/CD
%/NN
of/IN
the/DT
FAIRE-H3K4me3/NN
and/CC
FAIRE-H3K9/14ac/NN
regions/NNS
carrying/VBG
binding/VBG
motifs/NNS
were/VBD
distributed/VBN
at/IN
gene/NN
promoters/NNS
;/:
over/IN
20/CD
%/NN
in/IN
the/DT
gene/NN
body/NN
;/:
and/CC
at/IN
small/JJ
portions/NNS
far/RB
upstream/RB
of/IN
promoters/NNS
(/(
Fig/NN
./.
====================
3D/NN
and/CC
3E/NN
)/)
./.
====================
In/IN
contrast/NN
,/,
the/DT
population/NN
of/IN
FAIRE-H3K4me1/NN
was/VBD
highly/RB
enriched/VBN
in/IN
gene/NN
body/NN
regions/NNS
(/(
66.4/CD
%/NN
)/)
as/IN
well/RB
as/IN
upstream/RB
of/IN
promoters/NNS
(/(
31.3/CD
%/NN
)/)
but/CC
almost/RB
negligible/JJ
at/IN
promoters/NNS
(/(
2.3/CD
%/NN
)/)
(/(
Fig/NN
./.
====================
3C/NN
)/)
./.
====================
FAIRE/NN
has/VBZ
been/VBN
known/VBN
to/TO
enrich/JJ
functional/JJ
DNAs/NNS
located/JJ
in/IN
DNase/NN
I/CD
hypersensitive/JJ
sites/NNS
,/,
active/JJ
promoters/NNS
,/,
and/CC
transcriptional/JJ
start/NN
sites/NNS
[/(
22/CD
]/)
./.
====================
The/DT
enrichment/JJ
of/IN
such/JJ
regulatory/JJ
regions/NNS
in/IN
the/DT
aqueous/JJ
phase/NN
might/MD
result/VB
in/IN
easy/JJ
identification/NN
of/IN
genomic/JJ
function/NN
without/IN
bias/NNS
./.
====================
Eeckhoute/JJ
et/FW
al/JJ
./.
====================
[/(
23/CD
]/)
demonstrated/VBD
that/IN
FOXA1-bound/JJ
enhancers/NNS
defined/VBN
by/IN
FAIRE/NN
in/IN
human/JJ
chromosomes/NNS
8/CD
,/,
11/CD
,/,
and/CC
12/CD
were/VBD
closely/RB
related/JJ
with/IN
cell-type/JJ
specific/JJ
chromatin/NN
remodeling/NN
./.
====================
In/IN
addition/NN
,/,
it/PRP
was/VBD
reported/VBN
that/IN
FAIREs/NNS
are/VBP
highly/RB
associated/VBN
with/IN
DNase/NN
I/CD
hypersensitivity/NN
sites/NNS
,/,
RNA/NN
polymerase/NN
II/CD
,/,
and/CC
TAF1/NN
binding/NN
sites/NNS
[/(
22/CD
]/)
./.
====================
In/IN
combination/NN
with/IN
the/DT
information/NN
on/IN
these/DT
FAIRE/NN
regulatory/JJ
elements/NNS
in/IN
MCF-7/NN
cells/NNS
,/,
we/PRP
analyzed/VBD
our/PRP$
genomewide/NN
histone/NN
modification/NN
data/NNS
(/(
H3K4me1/NN
,/,
H3K4me3/NN
,/,
and/CC
H3K9/14ac/NN
)/)
generated/VBD
by/IN
ChIP-Seq/NN
[/(
26/CD
]/)
./.
====================
It/PRP
was/VBD
shown/VBN
that/IN
the/DT
H3K4me1/NN
distribution/NN
,/,
covering/VBG
the/DT
entire/JJ
human/JJ
genome/NN
,/,
which/WDT
was/VBD
different/JJ
from/IN
the/DT
pattern/NN
of/IN
H3K4me3/NN
and/CC
H3K9/14ac/NN
,/,
was/VBD
53/CD
%/NN
of/IN
the/DT
gene/NN
body/NN
,/,
42/CD
%/NN
of/IN
the/DT
intergenic/JJ
region/NN
,/,
and/CC
5/CD
%/NN
of/IN
the/DT
promoter/NN
./.
====================
The/DT
promoter/NN
regions/NNS
covered/VBD
54/CD
%/NN
and/CC
52/CD
%/NN
of/IN
total/JJ
sequence/NN
reads/VBZ
in/IN
H3K4me3/NN
and/CC
H3K9/14ac/NN
,/,
respectively/RB
./.
====================
The/DT
pair-wise/JJ
colocalization/NN
analysis/NN
between/IN
2/CD
histone/NN
modifications/NNS
gave/VBD
poor/JJ
correlation/NN
coefficients/NNS
in/IN
the/DT
H3K4me1-H3K4me3/NN
pair/NN
(/(
r/NN
=/JJ
0.14/CD
)/)
and/CC
H3K4me1-H3K9/14ac/JJ
pair/NN
(/(
r/NN
=/JJ
0.19/CD
)/)
but/CC
good/JJ
coincidence/NN
in/IN
the/DT
H3K4me3-H3K9/14ac/JJ
pair/NN
(/(
r/NN
=/JJ
0.86/CD
)/)
when/WRB
the/DT
Pearson/NN
's/POS
correlation/NN
coefficients/NNS
were/VBD
calculated/VBN
with/IN
normalized/VBN
tag/NN
counts/NNS
detected/VBN
within/IN
1/CD
kb/NN
upstream/RB
and/CC
downstream/JJ
of/IN
TSSs/NNS
[/(
26/CD
]/)
./.
====================
The/DT
co-occupancy/NN
of/IN
FAIRE/NN
elements/NNS
with/IN
histone/NN
modifications/NNS
is/VBZ
examined/VBN
in/IN
Fig/NN
./.
====================
1/CD
,/,
where/WRB
it/PRP
is/VBZ
clear/JJ
that/IN
the/DT
promoters/NNS
were/VBD
the/DT
most/JJS
abundant/JJ
regulatory/JJ
elements/NNS
./.
====================
Two/CD
active/JJ
histone/NN
modifications/NNS
,/,
H3K4me3/NN
and/CC
H3K9/14ac/NN
,/,
were/VBD
highly/RB
enriched/VBN
within/IN
±/CD
1/CD
kb/NN
from/IN
TSSs/NN
(/(
Fig/NN
./.
====================
1A/NN
)/)
,/,
and/CC
a/DT
comparative/JJ
analysis/NN
showed/VBD
that/IN
the/DT
FAIRE/NN
regulatory/JJ
elements/NNS
associated/VBN
with/IN
histone/NN
modifications/NNS
were/VBD
positioned/VBN
at/IN
promoters/NNS
(/(
Fig/NN
./.
====================
1D/CD
)/)
./.
====================
Such/JJ
epigenetic/JJ
relationship/NN
between/IN
FAIRE/NN
and/CC
active/JJ
histone/NN
modification/NN
marks/VBZ
has/VBZ
also/RB
been/VBN
demonstrated/VBN
in/IN
various/JJ
cell/NN
types/NNS
[/(
22/CD
,/,
23/CD
,/,
34-36/CD
]/)
./.
====================
As/IN
exemplified/VBN
in/IN
Fig/NN
./.
====================
1E/DT
,/,
H3K4me1/NN
was/VBD
differentially/RB
positioned/VBN
,/,
and/CC
the/DT
distribution/NN
of/IN
FAIRE-H3K4me1/NN
sites/NNS
was/VBD
away/NN
from/IN
promoter/NN
regions/NNS
,/,
meaning/VBG
that/DT
FAIRE-H3K4me1/NN
sites/NNS
might/MD
be/VB
distal/JJ
regulatory/JJ
elements/NNS
,/,
such/JJ
as/IN
enhancers/NNS
[/(
37/CD
]/)
./.
====================
The/DT
level/NN
of/IN
gene/NN
expression/NN
is/VBZ
also/RB
modulated/VBN
,/,
depending/VBG
on/IN
the/DT
degree/NN
and/CC
position/NN
of/IN
various/JJ
kinds/NNS
of/IN
histone/NN
modifications/NNS
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
2A-2C/NN
,/,
genes/NNS
with/IN
FAIRE/NN
sites/NNS
carrying/VBG
H3K4me3/NN
and/CC
H3K9/14ac/NN
had/VBD
relatively/RB
high/JJ
expression/NN
levels/NNS
compared/VBD
to/TO
those/DT
with/IN
FAIRE-H3K4me1/NN
./.
====================
Some/DT
genes/NNS
related/JJ
with/IN
breast/NN
cancer/NN
were/VBD
up-regulated/VBN
and/CC
showed/VBD
high/JJ
levels/NNS
of/IN
H3K9/14ac/NN
in/IN
our/PRP$
previous/JJ
study/NN
[/(
26/CD
]/)
./.
====================
We/PRP
therefore/RB
examined/VBN
68/CD
genes/NNS
with/IN
FAIRE-H3K9/14ac/NN
sites/NNS
with/IN
the/DT
DAVID/NN
GO/NN
analysis/NN
tool/NN
./.
====================
These/DT
genes/NNS
were/VBD
significantly/RB
related/JJ
with/IN
cell/NN
cycle/NN
,/,
apoptosis/NN
,/,
DNA/NN
damage/NN
,/,
and/CC
signaling/NN
pathways/NNS
,/,
reflecting/VBG
that/DT
their/PRP$
in/FW
vivo/FW
functions/NNS
are/VBP
essential/JJ
for/IN
cell/NN
survival/NN
and/CC
proliferation/NN
./.
====================
Many/JJ
of/IN
the/DT
regulatory/JJ
sites/NNS
associated/VBN
with/IN
histone/NN
modifications/NNS
contained/VBD
transcription/NN
factor/NN
binding/NN
motifs/NNS
(/(
Fig/NN
./.
====================
3A/NN
and/CC
3B/NN
)/)
./.
====================
CTCF/NN
binding/VBG
sites/NNS
,/,
commonly/RB
found/VBN
in/IN
FAIRE-H3K4me1/NN
,/,
FAIRE-H3K4me3/NN
,/,
and/CC
FAIRE-H3K9/14ac/NN
,/,
are/VBP
related/JJ
to/TO
a/DT
function/NN
of/IN
insulators/NNS
and/CC
involved/VBN
in/IN
high-order/JJR
chromatin/NN
structure/NN
[/(
38/CD
]/)
,/,
and/CC
DNA/NN
demethylation/NN
is/VBZ
also/RB
known/VBN
to/TO
be/VB
coincident/JJ
with/IN
FAIRE-related/JJ
open/JJ
chromatin/NN
[/(
36/CD
,/,
39/CD
]/)
./.
====================
Using/VBG
computational/JJ
motif/NN
analysis/NN
coupled/VBD
with/IN
ChIP/NN
assay/NN
,/,
Waki/NNP
et/FW
al/JJ
./.
====================
[/(
36/CD
]/)
demonstrated/VBD
that/IN
enrichment/JJ
of/IN
a/DT
binding/VBG
motif/NN
for/IN
nuclear/JJ
family/NN
I/NN
(/(
NFI/NN
)/)
transcription/NN
factors/NNS
was/VBD
highly/RB
associated/VBN
with/IN
adipocyte-specific/JJ
FAIRE/NN
signals/NNS
as/IN
well/RB
as/IN
active/JJ
histone/NN
modifications/NNS
,/,
like/IN
H3K4me3/NN
and/CC
H3K27ac/NN
,/,
providing/VBG
a/DT
global/JJ
view/NN
of/IN
cell/NN
type-specific/JJ
regulatory/JJ
elements/NNS
in/IN
the/DT
genome/NN
and/CC
an/DT
identification/NN
of/IN
transcriptional/JJ
regulators/NNS
of/IN
adipocyte/JJ
differentiation/NN
[/(
35/CD
]/)
./.
====================
Such/JJ
selective/JJ
activities/NNS
of/IN
regulatory/JJ
elements/NNS
were/VBD
also/RB
reported/VBD
by/IN
monitoring/VBG
the/DT
chromatin/NN
structure/NN
at/IN
FOXA1-bound/JJ
enhancers/NNS
defined/VBN
by/IN
FAIRE/NN
[/(
26/CD
]/)
./.
====================
This/DT
evidence/NN
supports/VBZ
the/DT
possibility/NN
that/IN
open/JJ
chromatin/NN
structures/NNS
are/VBP
subject/JJ
to/TO
be/VB
bound/VBN
by/IN
many/JJ
transcription/NN
factors/NNS
and/CC
that/IN
histone/NN
modifications/NNS
function/NN
as/IN
markers/NNS
for/IN
these/DT
factors/NNS
to/TO
be/VB
recruited/VBN
./.
====================
In/IN
conclusion/NN
,/,
our/PRP$
results/NNS
suggest/VBP
that/IN
genomic/JJ
regions/NNS
defined/VBN
by/IN
FAIRE/NN
in/IN
breast/NN
cancer/NN
cells/NNS
should/MD
be/VB
highly/RB
associated/VBN
with/IN
active/JJ
histone/NN
modifications/NNS
,/,
such/JJ
as/IN
H3K4me1/NN
,/,
H3K4me3/NN
,/,
and/CC
H3K9/14ac/NN
,/,
and/CC
play/VBP
a/DT
crucial/JJ
role/NN
in/IN
controlling/VBG
gene/NN
expression/NN
programs/NNS
./.
====================
This/DT
analysis/NN
will/MD
provide/VB
an/DT
understanding/NN
of/IN
epigenetic/JJ
regulatory/JJ
mechanisms/NNS
with/IN
open/JJ
chromatin/NN
in/IN
breast/NN
cancer/NN
cells/NNS
./.
====================
Chromatin/NN
structure/NN
in/IN
genomic/JJ
regions/NNS
defined/VBN
by/IN
formaldehyde-assisted/VBN
isolation/NN
of/IN
regulatory/JJ
elements/NNS
(/(
FAIRE/NN
)/)
in/IN
MCF7/NN
./.
====================
(/(
A/DT
)/)
Profile/JJ
of/IN
FAIRE/NN
and/CC
histone/NN
modifications/NNS
(/(
H3K4me1/NN
,/,
H3K4me3/NN
,/,
H3K9/14ac/NN
,/,
and/CC
H3K27me3/NN
)/)
on/IN
a/DT
chromosome/NN
scale/NN
(/(
chromosome/NN
8/CD
,/,
11/CD
,/,
and/CC
12/CD
)/)
./.
====================
The/DT
peaks/NNS
denoted/VBN
by/IN
spots/NNS
were/VBD
plotted/VBN
by/IN
k-clustering/VBG
using/VBG
seqMiner/NN
program/NN
./.
====================
(/(
B/NN
)/)
Histone/NN
modification/NN
peak/NN
profiles/NNS
were/VBD
analyzed/VBN
,/,
centered/JJ
on/IN
FAIRE/NN
signals/NNS
./.
====================
The/DT
Y/NN
axis/NN
represents/VBZ
the/DT
normalized/VBN
sum/NN
of/IN
peak/NN
counts/NNS
,/,
multiplied/JJ
by/IN
10,000/CD
./.
====================
(/(
C/NN
)/)
The/DT
overlapping/JJ
of/IN
each/DT
FAIRE-histone/NN
modification/NN
was/VBD
estimated/VBN
./.
====================
(/(
D/NN
)/)
FAIRE-histone/NN
modifications/NNS
ranging/VBG
from/IN
-5/CD
kb/NN
to/TO
5/CD
kb/NN
of/IN
transcription/NN
start/NN
sites/NNS
(/(
TSSs/NNS
)/)
were/VBD
plotted/VBN
./.
====================
(/(
E/NN
)/)
Chromatin/NN
state/NN
at/IN
CCND1/NN
locus/NN
./.
====================
The/DT
box/NN
indicates/VBZ
±3/NN
kb/NN
region/NN
from/IN
TSS/NN
./.
====================
Formaldehyde-assisted/JJ
isolation/NN
of/IN
regulatory/JJ
elements/NNS
(/(
FAIRE/NN
)/)
-histone/NN
modifications/NNS
and/CC
gene/NN
expression/NN
profile/NN
./.
====================
(/(
A/NN
)/)
Gene/NN
expression/NN
level/NN
and/CC
histone/NN
modification/NN
enrichment/JJ
./.
====================
Inserts/NNS
are/VBP
Pearson/NN
correlation/NN
coefficients/NNS
(/(
r/NN
)/)
./.
====================
(/(
B/NN
)/)
Gene/NN
expression/NN
level/NN
and/CC
histone/NN
H3K4me3/NN
enrichment/JJ
./.
====================
(/(
C/NN
)/)
Gene/NN
expression/NN
level/NN
and/CC
histone/NN
H3K9/14ac/NN
enrichment/JJ
./.
====================
(/(
D/NN
)/)
Gene/NN
ontology/NN
(/(
GO/NN
)/)
analysis/NN
for/IN
top/NN
30/CD
%/NN
ranked/VBD
expressed/VBN
genes/NNS
in/IN
H3K9/14ac/NN
enrichment/JJ
./.
====================
(/(
E/NN
)/)
Kyoto/NN
Encyclopedia/NN
of/IN
Genes/NNS
and/CC
Genomes/NNS
(/(
KEGG/NN
)/)
pathway/NN
analysis/NN
for/IN
top/NN
30/CD
%/NN
ranked/VBD
expressed/VBN
genes/NNS
in/IN
H3K9/14ac/NN
enrichment/JJ
./.
====================
MAPK/NN
,/,
mitogen-activated/JJ
protein/NN
kinase/NN
./.
====================
Motif/DT
analysis/NN
for/IN
formaldehyde-assisted/VBN
isolation/NN
of/IN
regulatory/JJ
elements/NNS
(/(
FAIRE/NN
)/)
-related/JJ
genomic/JJ
regions/NNS
marked/JJ
by/IN
H3K4me1/NN
,/,
H3K4me3/NN
,/,
and/CC
H3K9/14ac/NN
./.
====================
(/(
A/NN
)/)
Motif/NN
analysis/NN
for/IN
FAIRE/NN
marked/JJ
by/IN
H3K4me3/NN
and/CC
H3K9/14ac/NN
./.
====================
(/(
B/NN
)/)
Motif/NN
analysis/NN
for/IN
FAIRE/NN
marked/JJ
by/IN
H3K4me1/NN
./.
====================
(/(
C/NN
)/)
Genomic/JJ
distribution/NN
of/IN
motifs/NNS
identified/VBD
from/IN
FAIRE-H3K4me1/NN
./.
====================
(/(
D/NN
)/)
Genomic/JJ
distribution/NN
of/IN
motifs/NNS
identified/VBD
from/IN
FAIRE-H3K4me3/NN
./.
====================
(/(
E/NN
)/)
Genomic/JJ
distribution/NN
of/IN
motifs/NNS
identified/VBD
from/IN
FAIRE-H3K9/14ac/NN
./.
====================
N.D./NN
,/,
not/RB
determined/VBN
./.
====================
aUpstream/RB
regions/NNS
from/IN
transcription/NN
start/NN
sites/NNS
./.
====================
The/DT
number/NN
of/IN
peaks/NNS
of/IN
formaldehyde-assisted/VBN
isolation/NN
of/IN
regulatory/JJ
elements/NNS
(/(
FAIRE/NN
)/)
and/CC
histone/NN
modifications/NNS
analyzed/VBD
in/IN
this/DT
study/NN
====================
